Selecta Biosciences (SELB) Short Interest Ratio & Short Volume

Short interest is the volume of Selecta Biosciences shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 7,980,000 shares of SELB short. 7.18% of Selecta Biosciences' shares are currently sold short. Learn More on Selecta Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SELB shares currently have a short interest ratio of 14.0. Learn More on Selecta Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.18% of Selecta Biosciences' floating shares are currently sold short.

Selecta Biosciences saw a decrease in short interest in October. As of October 31st, there was short interest totaling 7,980,000 shares, a decrease of 12.0% from the previous total of 9,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Selecta Biosciences currently has issued a total of 155,200,000 shares. Some of Selecta Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Selecta Biosciences currently has a public float of 111,130,000 shares.

7.18% of Selecta Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Selecta Biosciences: NGM Biopharmaceuticals, Inc. (4.52%), Kinnate Biopharma Inc. (2.01%), CytomX Therapeutics, Inc. (5.30%), LianBio (0.36%), Sagimet Biosciences Inc. (12.02%), Syros Pharmaceuticals, Inc. (10.10%), DBV Technologies S.A. (0.27%), Agenus Inc. (13.01%), Augmedix, Inc. (2.83%), Molecular Partners AG (0.16%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($9.07 billion), T-Mobile US, Inc. ($3.71 billion), Charter Communications, Inc. ($3.51 billion), Occidental Petroleum Co. ($2.81 billion), Lululemon Athletica Inc. ($2.35 billion), Tractor Supply ($2.26 billion), Coinbase Global, Inc. ($1.88 billion), Rivian Automotive, Inc. ($1.71 billion), Celsius Holdings, Inc. ($1.67 billion), and Newmont Co. ($1.66 billion). View all of the most shorted stocks.

Short selling SELB is an investing strategy that aims to generate trading profit from Selecta Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Selecta Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SELB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SELB, twice per month. The most recent reporting period available is October, 31 2023.